Phillip Sharp

Phillip Allen Sharp was the founder of Dewpoint Therapeutics, Inc. (founded 2018), Biogen, Inc. (founded 1978) where the title held was Director from 2003 to 2009, PPD Dermatology LLC (founded 2006) where the title held was Director, and Alnylam Pharmaceuticals, Inc. (founded 2002) where the title held was Independent Director from 2002 to 2025.
Current jobs include Director at Whitehead Institute for Biomedical Research, Director at The Broad Institute, Inc., Professor at Massachusetts Institute of Technology since 1999, Member of The Royal Society, Member of National Academy of Sciences, Member of American Academy of Arts & Sciences, Member of National Academy of Medicine (United States), Member of American Philosophical Society, and Professor at David H.
Koch Institute for Integrative Cancer Research.
Former jobs include Director at Center for Cancer Research from 1985 to 1991, Director & Strategic Advisor at Longwood Fund Management LLC, Independent Director at Syros Pharmaceuticals, Inc. from 2012 to 2022, Director at McGovern Institute For Brain Research from 2000 to 2004, and Independent Director at Vir Biotechnology, Inc. from 2017 to 2024.
Education history includes undergraduate degree from Union College (Kentucky) conferred in 1966 and doctorate from the University of Illinois conferred in 1969.